Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q1 2022
Institutional positions in Vigil Neuroscience, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +47 vs. Q4 2021
- Shares held
- 17.9M
- +17.9M vs. Q4 2021
- Total value
- $125.1M
- +$125.1M vs. Q4 2021
- New holders
- 47
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Legal & General Group Plc | 634 | $4.00K | 0.00% | +634 | New |
| Ameritas Investment Partners, Inc. | 500 | $4.00K | 0.00% | +500 | New |
| High Net Worth Advisory Group LLC | 500 | $4.00K | 0.00% | +500 | New |
| UBS Group AG | 920 | $6.00K | 0.00% | +920 | New |
| Morgan Stanley | 876 | $7.00K | 0.00% | +876 | New |
| Royal Bank of Canada | 1,037 | $7.00K | 0.00% | +1,037 | New |
| Cubist Systematic Strategies, LLC | 1,000 | $7.00K | 0.00% | +1,000 | New |
| Wells Fargo & Company | 1,465 | $10.0K | 0.00% | +1,465 | New |
| Bank of America Corp | 1,519 | $11.0K | 0.00% | +1,519 | New |
| STRS Ohio | 1,600 | $11.0K | 0.00% | +1,600 | New |
| Tower Research Capital LLC (TRC) | 1,773 | $12.0K | 0.00% | +1,773 | New |
| Amalgamated Bank | 2,451 | $17.0K | 0.00% | +2,451 | New |
| Amalgamated Financial Corp. | 2,451 | $17.0K | 0.00% | +2,451 | New |
| California State Teachers Retirement System | 2,795 | $20.0K | 0.00% | +2,795 | New |
| JPMorgan Chase & Co | 3,148 | $22.0K | 0.00% | +3,148 | New |
| American International Group, Inc. | 3,332 | $23.0K | 0.00% | +3,332 | New |
| Deutsche Bank AG | 3,747 | $26.0K | 0.00% | +3,747 | New |
| New York State Common Retirement Fund | 8,500 | $60.0K | 0.00% | +8,500 | New |
| Point72 Hong Kong Ltd | 12,667 | $89.0K | 0.01% | +12,667 | New |
| Bank of New York Mellon Corp | 13,341 | $94.0K | 0.00% | +13,341 | New |
| Charles Schwab Investment Management Inc | 19,198 | $135.0K | 0.00% | +19,198 | New |
| Millennium Management LLC | 19,930 | $140.0K | 0.00% | +19,930 | New |
| Renaissance Technologies LLC | 20,041 | $141.0K | 0.00% | +20,041 | New |
| LMR Partners LLP | 27,642 | $194.0K | 0.00% | +27,642 | New |
| Davidson Kempner Capital Management LP | 30,000 | $211.0K | 0.00% | +30,000 | New |
| State Street Corp | 54,479 | $383.0K | 0.00% | +54,479 | New |
| Northern Trust Corp | 56,683 | $398.0K | 0.00% | +56,683 | New |
| Citigroup Inc | 64,094 | $451.0K | 0.00% | +64,094 | New |
| Goldman Sachs Group Inc | 73,839 | $519.0K | 0.00% | +73,839 | New |
| Caas Capital Management LP | 75,000 | $527.0K | 0.09% | +75,000 | New |
| Squarepoint Ops LLC | 86,193 | $606.0K | 0.00% | +86,193 | New |
| Geode Capital Management, LLC | 97,080 | $682.0K | 0.00% | +97,080 | New |
| DAFNA Capital Management LLC | 99,754 | $701.0K | 0.18% | +99,754 | New |
| Barclays PLC | 102,773 | $722.0K | 0.00% | +102,773 | New |
| Logos Global Management LP | 205,595 | $1.45M | 0.19% | +205,595 | New |
| Harvard Management Co Inc | 289,460 | $2.04M | 0.21% | +289,460 | New |
| BlackRock Inc. | 303,689 | $2.13M | 0.00% | +303,689 | New |
| Vanguard Group Inc | 385,198 | $2.71M | 0.00% | +385,198 | New |
| Deep Track Capital, LP | 389,141 | $2.74M | 0.18% | +389,141 | New |
| OrbiMed Advisors LLC | 411,191 | $2.89M | 0.05% | +411,191 | New |
| Rock Springs Capital Management LP | 471,958 | $3.32M | 0.08% | +471,958 | New |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $3.94M | 1.86% | +560,595 | New |
| Cormorant Asset Management, LP | 616,786 | $4.21M | 0.32% | +616,786 | New |
| Artal Group S.A. | 1,121,191 | $7.88M | 0.33% | +1,121,191 | New |
| Citadel Advisors LLC | 2,162,639 | $14.9M | 0.02% | +2,162,639 | New |
| Northpond Ventures, LLC | 4,214,498 | $29.6M | 15.97% | +4,214,498 | New |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $41.0M | 5.19% | +5,836,874 | New |